This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Tuesday's Small-Cap Winners & Losers

General Employment Enterprises (JOB - Get Report) surged after the staffing-services firm tripled its fiscal first-quarter income from last year to $296,000, or 6 cents a share. Revenue edged up 3% to $4.8 million year over year. The Illinois-based company's stock was rising 32 cents, or 17.2%, to $2.18.

Winland Electronics (WEX - Get Report) jumped after the Mankato, Minn.-based company said it signed a yearlong contract with an unnamed customer to make an "innovative security product for law enforcement applications" that will potentially generate more than $1 million over the life of the agreement, depending on the customer's success at selling the product to municipalities and law enforcement outfits. Winland says it shipped $140,000 worth of the product to the customer in the last quarter and will ship $350,000 more in the current one. Shares were adding 40 cents, or 11.7%, to $3.82.

Alfacell (ACEL) was riding high on news that the Food and Drug Administration had granted its Onconase product orphan-drug designation for the treatment of malignant mesothelioma, a rare form of lung cancer. This will afford the Bloomfield, N.J., company seven years of marketing exclusivity should the FDA approve the drug for that use, as well as eligibility for tax credits, funding and other benefits. Alfacell is currently testing the product for the unresectable form of the disease (meaning those tumors that cannot be surgically removed) in a Phase IIIb trial. Shares were gaining 12 cents, or 7.4%, to $1.75.

2 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
VLTR $22.97 -0.13%
ALGN $59.18 0.00%
ASYS $12.04 0.00%
COOL $1.34 0.00%
CGEN $7.00 0.00%

Markets

DOW 18,080.14 +21.45 0.12%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs